|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Boerhavia erecta, an annual herb, has been used in folklore for managing of a wide range of diseases including cancer. However, the safety and effectiveness of this medicinal plant was better evaluated. The intention of this study was to evaluate the in-vitro antioxidant and anticancer activities of whole plant extract of Boerhavia erecta well as the qualitative phytochemical constituents. The DPPH and nitric oxide scavenging assays were used to evaluate the plant’s antioxidant potential. The in-vitro3-(4, 5- Dimethylthiazol-2-yl)-2, 5-Diphenyltetrazolium Bromide (MTT) assay was exploited for determination of in-vitro anticancer activity against two cell lines: Mouse fibroblastic cell lines (L929), it’s a normal cell line and human brain tumor cell lines (U87), it’s a cancer cell line. Ascorbic acid and quercetin were used a standard antioxidant compound. The IC50 and CTC50 values were also estimated for antioxidant and anticancer studies respectively.